American Heart Journal
Volume 158, Issue 3 , Pages 400-407 , September 2009

ST-elevation myocardial infarction patients can be enrolled in randomized trials before emergent coronary intervention without sacrificing door-to-balloon time

  • James C. Blankenship, MD

      Affiliations

    • Department of Cardiology, Geisinger Medical Center, Danville, PA
    • Corresponding Author InformationReprint requests: James C. Blankenship, MD, Department of Cardiology 21-60, Geisinger Medical Center, 100 North Academy Drive, Danville, PA 17822.
    • ,
  • Kimberly A. Skelding, MD

      Affiliations

    • Department of Cardiology, Geisinger Medical Center, Danville, PA
    • ,
  • Thomas D. Scott, DO

      Affiliations

    • Department of Cardiology, Geisinger Medical Center, Danville, PA
    • ,
  • Jeremy Buckley, MD

      Affiliations

    • Department of Cardiology, Geisinger Medical Center, Danville, PA
    • ,
  • Deborah K. Zimmerman, RN MHSA

      Affiliations

    • CardioKinetix, Inc., Menlo Park, CA
    • ,
  • Amy Temple, RN

      Affiliations

    • Department of Cardiology, Geisinger Medical Center, Danville, PA
    • ,
  • Jennifer Sartorius, MS

      Affiliations

    • Center for Health Research, Geisinger Health System, Danville, PA
    • ,
  • Enrique Jimenez, MD

      Affiliations

    • Department of Cardiology, Geisinger Medical Center, Danville, PA
    • ,
  • Peter B Berger, MD

      Affiliations

    • Department of Cardiology, Geisinger Medical Center, Danville, PA

Received 14 April 2009 ,Accepted 21 June 2009.

References 

  1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13–20
  2. Jollis J, Roettig M, Aluko A, et al. Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction. JAMA. 2007;298:2371–2380
  3. Aguirre F, Varghese J, Kelley M, et al. Rural interhospital transfer of ST-elevation myocardial infarction patients for percutaneous coronary revascularization: the Stat Heart Program. Circulation. 2008;117:1145–1152
  4. Ting H, Rihal C, Gersh B, et al. Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction. The Mayo Clinic STEMI Protocol. Circulation. 2007;116:729–736
  5. Henry T, Sharkey S, Nicholas B, et al. A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation. 2007;116:721–728
  6. Blankenship J, Haldis T, Wood C, et al. Rapid triage and transport of patients with ST-elevation myocardial infarction for percutaneous coronary intervention in a rural health system. Am J Cardiol. 2007;100:944–948
  7. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients with Acute Myocardial Infarction. J Am Coll Cardiol. 2004;44:671–719
  8. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction). J Am Coll Cardiol. 2008;51:210–247
  9. Ornato J. Accelerating time to reperfusion in acute myocardial infarction: prehospital and emergency department strategies, systems of care and pharmacologic interventions. Rev Cardiovasc Med. 2006;7:S49–S60
  10. Faxon D, Jacobs A. Strategies to improve early reperfusion in ST-elevation myocardial infarction. Rev Cardiovasc Med. 2007;8:127–134
  11. Boden W, Eagle K, Granger C. Reperfusion strategies in acute ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2007;50:917–929
  12. McKay RG. Evolving strategies in the treatment of acute myocardial infarction in the community hospital. J Am Coll Cardiol. 2003;42:642–645
  13. Berger JS, Roe MR, Gibson CM, et al. Safety and feasibility of adjunctive antiplatelet therapy with intravenous PRT0060128, a selective P2Y12 receptor inhibitor, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid Reversal of Platelet Thrombosis with Intravenous PRT060128 before PCI to Optimize Reperfusion in Acute Myocardial Infarction (ERASE MI) Trial. Submitted.
  14. The APEX Investigators . Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: A randomized controlled trial. JAMA. 2007;297:43–51
  15. Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358:2218–2230
  16. Stone GW, Martin JL, Menko JDB, et al. Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction. Circculation:Cardiovasc Intervent (in press).
  17. Pinto DS, Kirtane AJ, Nallamothu BK, et al. Hospital delays in reperfusion for ST-elevation myocardial infarction. Circulation. 2006;114:2019–2025
  18. Eagle KA, Nallamothu BK, Mehta R, et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J. 2008;29:609–617
  19. Mehta RH, Bufalino VJ, Pan W, et al. Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: insights from American Heart Association's Get With the Guidelines Program. Am Heart J. 2008;155:1059–1067
  20. Nallamothu BK, Bates ER, Herrin ER, et al. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States. Circulation. 2005;111:761–767
  21. Dhruva VN, Abdelhadi SI, Anis A, et al. ST-segment Analysis Using Wireless Technology in Acute Myocardial Infarction (STAT-MI) Trial. J Am Coll Cardiol. 2007;50:509–513
  22. Sejerstein M, Sillesen M, Hansen PR, et al. Effect on treatment delay of prehospital teletransmission of a 12-lead electrocardiogram to a cardiologist for immediate triage and direct referral of patients with ST-segment elevation acute myocardial infarction to a primary percutaneous coronary intervention. Am J Cardiol. 2008;101:941–946
  23. Brown JP, Mahmud E, Dunford JV, et al. Effect of prehospital 12-lead electrocardiogram on activation of the cardiac catheterization laboratory and door-to-balloon time in ST-segment elevation acute myocardial infarction. Am J Cardiol. 2008;101:158–161
  24. Curtis JP, Portnay EL, Wang Y, et al. The pre-hospital electrocardiogram and time to reperfusion in patients with acute myocardial infarction, 2000-2002. Findings from the National Registry of Myocardial Infarction-4. J Am Coll Cardiol. 2006;47:1544–1552
  25. Gross BW, Dauterman KW, Moran MG, et al. An approach to shorten time to infarct artery patency in patients with ST-elevation myocardial infarction. Am J Cardiol. 2007;99:1360–1363
  26. Ting HH, Krumholz HM, Bradley EH, et al. Implementation and integration of prehospital ECGs into systems of care for acute coronary syndrome. A scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursing, and Council on Clinical Cardiology. Circulation. 2008;118:1066–1079
  27. Garvey JL, MacLeod BA, Sopko G, et al. Pre-hospital 12-lead electocardiography programs. A call for implementation by emergency medical services systems providing advanced life support-National Heart Attack Alert Program (NHAAP) Coordinating Committee; National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health. J Am Coll Cardiol. 2006;47:485–491
  28. Concannon TW, Kent DM, Normand SL, et al. A geospatial analysis of emergency transport and inter-hospital transfer in ST-segment elevation myocardial infarction. Am J Cardiol. 2008;101:69–74
  29. Magid DJ, Wang Y, Herrin J, et al. Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction. JAMA. 2005;294:803–812
  30. Wu EB, Arora N, Eisenhauer AC, et al. An analysis of door-to-balloon time in a single center to determine causes of delay and possibilities for improvement. Cathet Cardiovasc Intervent. 2007;71:152–157
  31. Krüth P, Zeymer U, Gitt A, et al. Influence of presentation at the weekend on treatment and outcome in ST-elevation myocardial infarction in hospitals with catheterization laboratories. Clin Res Cardiol. 2008;97:742–747
  32. Blankenship JC, Sledgen M, Skelding KA, et al. Efficient referring hospitals can routinely transfer patients for STEMI PCI with door-to-balloon times <90 minutes. J Am Coll Cardiol. 2008;51:A267
  33. Gonzales SK, Helling TH. Effect of the Final Rule on the conduct of emergency clinical research. J Trauma. 2008;64:1665–1672
  34. Biros MH, Lewis RJ, Olson CM, et al. Informed consent in emergency research: Consensus statement from the Coalition Conference of Acute Resuscitation and Critical Care Researchers. JAMA. 1995;273:1283–1287
  35. McRae A, Weijer CU. S. federal regulations for emergency research: a practical guide and commentary. Acad Emerg Med. 2008;15:88–97
  36. Grim PS, Singer PA, Gramelspacher GP, et al. Informed consent in emergency research. Prehospital thrombolytic therapy for acute myocardial infarction. JAMA. 1989;262:252–255
  37. Kucia AM, Horowitz JD. Is informed consent to clinical trials an upside selective process in acute coronary syndromes?. Am Heart J. 2000;140:94–97
  38. Agard A, Herlitz J, Hermeren G. Obtaining informed consent from patients in the early phase of acute myocardial infarction: physicians' experiences and attitudes. Heart. 2004;90:208–210
  39. Foex BA. Is informed consent possible in acute myocardial infarction?. Heart. 2004;90:1237–1238
  40. Smithline HA, Mader TJ, Crenshaw BJ. Do patients with acute medical conditions have the capacity to give informed consent for emergency medicine research?. Acad Emerg Med. 1999;6:776–780
  41. Agard A, Hermeren G, Herlitz J. Patients' experiences of intervention trials on the treatment of myocardial infarction: is it time to adjust the informed consent procedure to the patient's capacity?. Heart. 2001;86:632–637
  42. Williams BF, French JK, White HD. Informed consent during the clinical emergency of acute myocardial infarction (HERO-2 consent substudy): a prospective observational study. Lancet. 2003;361:918–922
  43. Gammelgaard A, Mortensen OS, Rossel P. Patients' perceptions of informed consent in acute myocardial infarction research: a questionnaire based survey of the consent process in the DANAMI-2 trial. Heart. 2004;90:1124–1128
  44. Ockene IS, Miner J, Shannon TA, et al. The consent process in the Thrombolysis in Myocardial Infarction (TIMI-Phase I) Trial. Clin Res. 1991;39:13–17
  45. Yuval R, Halon DA, Merdler A, et al. Patient comprehension and reaction to participating in a double-blind randomized clinical trial (ISIS-4) in acute myocardial infarction. Arch Int Med. 2000;160:1142–1146
  46. Richmond TS, Ulrich C. Ethical issues of recruitment and enrollment of critically ill and injured patients for research. AACN Adv Crit Care. 2007;18:352–355
  47. Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Eng J Med. 2006;355:2308–2320

PII: S0002-8703(09)00477-3

doi: 10.1016/j.ahj.2009.06.022

American Heart Journal
Volume 158, Issue 3 , Pages 400-407 , September 2009

Article Tools